Claudin-1 (1-18)

General Information


DRACP ID  DRACP04019

Peptide Name   Claudin-1 (1-18)

Sequence  MANAGLQLLGFILAFLGW

Sequence Length  18

UniProt ID  O95832 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C94H143N21O21S

Absent amino acids  CDEHKPRSTVY

Common amino acids  L

Mass  223880

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  12

Net charge  0

Boman Index  3623

Hydrophobicity  151.67

Aliphatic Index  146.67

Half Life 
  Mammalian: 1 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  323.53

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22378192

Title  A human claudin-1-derived peptide inhibits hepatitis C virus entry

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15777

DRACP is developed by Dr.Zheng's team.